Actelion Ltd. Board Nominees Deny Sale is Main Aim

April 4, 2011 |

1 min read

(Reuters) - A group of prospective Actelion board members denied speculation they planned to prepare Europe's biggest biotech for sale and said they wanted instead to overhaul it.

Mergers & acquisitions

MORE ON THIS TOPIC

Vector illustration of two businessmen engaged in a hand wrestling match, symbolizing competition, rivalry, power struggles, competitive environments, and conflict resolution concepts

Mergers & acquisitions

UPDATE: Novo Nordisk Seeks To Steal Metsera From Pfizer With $8.5B Offer

October 30, 2025

·

4 min read

·

Annalee Armstrong

Podcast

Novartis’ Big Buy, Q3 Earnings, Regeneron’s Dropped Cell Therapy, More

October 29, 2025

·

1 min read

·

Heather McKenzie

A hand in a medical or laboratory glove holds a laboratory flask with coins with dollar sign. Investments in laboratory research and science. Concept of profit, making money, business. Modern design. Copy space.

Earnings

Novartis CEO Says Trump’s Drug Pricing Deals Don’t Address Root Problem

October 28, 2025

·

3 min read

·

Annalee Armstrong

3D illustration of many pawns attracted by a red one. Concept of aura of attraction and charismatic person.3D rendering on black background.

Rare diseases

Dyne Primed for Suitors Amid Novartis’ $12B Avidity Acquisition

October 27, 2025

·

2 min read

·

Tristan Manalac